Dr. Peter McCullough and Dr. Greg Marchand Publish the Definitive Analysis of RSV Vaccine Safety in Pregnancy
Just published in the Journal of Clinical and Translational Research, The Marchand Institute’s new study on 20% intravenous fat emulsion therapy (also known as IntralipidTM), shows the effect of this medication on patients who suffer from recurrent pregnancy loss (RPL) and recurrent implantation failure (RIF) who are seeking to conceive via invitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). The article is available online complete free at the US Government’s Pubmed website as well as Semantic ScholarTM.
Related posts
